A Single-Center, Open-Label Study Evaluating the Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Lowering Intraocular Pressure Over a 24-Hour Period in Japanese Healthy Male Volunteers

Trial Profile

A Single-Center, Open-Label Study Evaluating the Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Lowering Intraocular Pressure Over a 24-Hour Period in Japanese Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2015

At a glance

  • Drugs Latanoprostene bunod (Primary)
  • Indications Ocular hypertension
  • Focus Pharmacodynamics
  • Acronyms KRONUS
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 12 Nov 2015 Results published in the Advances in Therapy
    • 15 May 2014 According to the Nicox media release, results of this trial were presented at Association for Research in Vision and Ophthalmology (ARVO) Annual meeting in Orlando, Florida on May 4-8 2014.
    • 06 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top